Telos Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Telos Capital Management, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $63.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$63.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 46,466 | $11.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 23,234 | $10.4M |
| AMGNAMGEN INC | 26,012 | $9.2M |
| IQVIQVIA Holdings Inc. | 46,575 | $7.9M |
| BMYBRISTOL MYERS SQUIBB CO | 116,088 | $7.0M |
| ABBVAbbVie Inc. | 18,719 | $4.1M |
| NVSNovartis AG | 25,703 | $3.9M |
| ABTABBOTT LABORATORIES | 28,859 | $3.0M |
| LLYELI LILLY & Co | 2,301 | $2.1M |
| MRKMerck & Co., Inc. | 14,360 | $1.7M |
| PFEPFIZER INC | 25,780 | $724K |
| PMPhilip Morris International Inc | 3,358 | $555K |
| REGNREGENERON PHARMACEUTICALS, INC. | 482 | $372K |
| CAHCardinal Health Inc. | 1,286 | $272K |
| VTRSViatris Inc | 15,382 | $208K |
| GILDGILEAD SCIENCES, INC. | 1,436 | $200K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.